Triple

T1143271
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EC) No 726/2004 E23503 entity
Predicate establishes P986 FINISHED
Object Committee for Medicinal Products for Veterinary Use within the European Medicines Agency E24385 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Committee for Medicinal Products for Veterinary Use within the European Medicines Agency | Statement: [Regulation (EC) No 726/2004, establishes, Committee for Medicinal Products for Veterinary Use within the European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Committee for Medicinal Products for Veterinary Use within the European Medicines Agency
Context triple: [Regulation (EC) No 726/2004, establishes, Committee for Medicinal Products for Veterinary Use within the European Medicines Agency]
  • A. Committee for Medicinal Products for Veterinary Use chosen
    The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
  • B. Veterinary Medicines Directorate
    The Veterinary Medicines Directorate is a UK government agency responsible for regulating veterinary medicines and ensuring their safety, quality, and effectiveness in animals and the food chain.
  • C. Coordination Group for Mutual Recognition and Decentralised Procedures – Veterinary
    The Coordination Group for Mutual Recognition and Decentralised Procedures – Veterinary (CMDv) is a European regulatory body that coordinates and harmonises the assessment and approval of veterinary medicines across EU member states under mutual recognition and decentralised procedures.
  • D. Management Board of the European Medicines Agency
    The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
  • E. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493ef399c8190b04b9146d2314f59 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4bc4e93d48190b9fea886bf61aad7 completed March 1, 2026, 10:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac5eb1f7d08190ba722dcbbc8a6799 completed March 7, 2026, 5:21 p.m.
Created at: March 1, 2026, 7:44 p.m.